Epidemiology of Schizophrenia in Bulgaria

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00984373
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to provide accurate, reliable information on schizophrenia clinical management in order to detect unmet medical needs of this disease in terms of:

* Patient characteristics.

* Diagnostic and treatment approaches: initial and subsequent.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09
• Study First Submitted: 2009-09-24
• Study First Submitted QC: 2009-09-24
• Study First Posted: 2009-09-25
• Primary Completion: 2009-11
• Study Completion: 2009-11
• Status Verified: 2010-02
• Last Update Submitted: 2010-02-02
• Last Update Posted: 2010-02-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 440

Inclusion Criteria

• Patients with schizophrenia
• Above 18 years
• Signed Informed consent

Exclusion Criteria

• Below 18 years
• Consent refused

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Research Site; 🇧🇬 Vidin, Bulgaria